Literature DB >> 23860950

Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study.

Ping-Ping Bao1, Ying Zheng, Sarah Nechuta, Kai Gu, Hui Cai, Peng Peng, Xiao-Ou Shu, Wei Lu.   

Abstract

Metabolic syndrome (MetS) is an established risk factor for cardiovascular diseases and mortality. Limited data are available on the prevalence of MetS and its association with exercise among breast cancer survivors. The present study included 1,696 breast cancer survivors from the Shanghai Breast Cancer Survival Study, a population-based prospective cohort study conducted between April 2002 and October 2011 in Shanghai, China. All women had a physical examination taken at study clinic approximately 60 months post-diagnosis. Exercise was assessed at approximately 6, 18, 36, and 60 months post-diagnosis. Information on medical history, tumor characteristics, cancer treatment, anthropometrics, and lifestyle was collected at study enrollment. Associations between exercise and MetS at 60 months post-diagnosis were evaluated with multivariable logistic regression models. The mean age of the study population was 56.68 at 60-month survey, and the mean follow-up since cancer diagnosis was 63.66 months. The prevalence of MetS using National Cholesterol Education Program Adult Treatment Panel III criteria at approximately 60 months after diagnosis was 33.14%. Among overweight and obesity breast cancer survivors (body mass index (BMI) ≥ 25 kg/m(2) at baseline), the prevalence was 55.18%. The most common type of exercise in this population was walking (45.40%) at baseline. Exercise participation between 6 and 60 months post-diagnosis was inversely associated with the prevalence of MetS with the adjusted odds ratio (OR) for exercise participation of ≥ 3.5 h/week (30 min/day) being 0.69 (95% confidence interval (CI) 0.48-0.98). In addition consistent exercise participation reduced the prevalence of MetS (adjusted OR 0.70 (95% CI 0.50-1.00). Associations of exercise with MetS were not modified by baseline waist circumference, BMI, comorbidity, baseline menopausal status, TNM stage, cancer treatment, or ER/PR status (p interactions > 0.05). Regular and persistent exercise after cancer diagnosis, even at low-to-moderate intensity level, decreases the prevalence of MetS among long-term breast cancer survivors.

Entities:  

Mesh:

Year:  2013        PMID: 23860950      PMCID: PMC3858324          DOI: 10.1007/s10552-013-0252-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  44 in total

Review 1.  The metabolic syndrome in adult survivors of childhood cancer, a review.

Authors:  Marjolein van Waas; Sebastian J Neggers; Aart-Jan van der Lelij; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  J Pediatr Hematol Oncol       Date:  2010-04       Impact factor: 1.289

Review 2.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

3.  Longitudinal study of recreational physical activity in breast cancer survivors.

Authors:  Alyson J Littman; Mei-Tzu Tang; Mary Anne Rossing
Journal:  J Cancer Surviv       Date:  2010-02-24       Impact factor: 4.442

4.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Authors:  Pamela J Goodwin; Marguerite Ennis; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Yolanda Madarnas; Warren Hartwick; Barry Hoffman; Nicky Hood
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

5.  Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003-2006).

Authors:  Brigid M Lynch; David W Dunstan; Genevieve N Healy; Elisabeth Winkler; Elizabeth Eakin; Neville Owen
Journal:  Cancer Causes Control       Date:  2009-11-01       Impact factor: 2.506

6.  Medical comorbidities predict mortality in women with a history of early stage breast cancer.

Authors:  Ruth E Patterson; Shirley W Flatt; Nazmus Saquib; Cheryl L Rock; Bette J Caan; Barbara A Parker; Gail A Laughlin; Kirsten Erickson; Cynthia A Thomson; Wayne A Bardwell; Richard A Hajek; John P Pierce
Journal:  Breast Cancer Res Treat       Date:  2010-01-14       Impact factor: 4.872

7.  Serum testosterone levels and breast cancer recurrence.

Authors:  Franco Berrino; Patrizia Pasanisi; Cristina Bellati; Elisabetta Venturelli; Vittorio Krogh; Antonio Mastroianni; Edoardo Berselli; Paola Muti; Giorgio Secreto
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

Review 8.  The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures.

Authors:  Janine Nuver; Andries J Smit; Aleida Postma; Dirk Th Sleijfer; Jourik A Gietema
Journal:  Cancer Treat Rev       Date:  2002-08       Impact factor: 12.111

9.  Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.

Authors:  Cynthia A Thomson; Patricia A Thompson; Jennifer Wright-Bea; Emily Nardi; Georgette R Frey; Alison Stopeck
Journal:  J Womens Health (Larchmt)       Date:  2009-12       Impact factor: 2.681

10.  Anthropometric changes using a walking intervention in African American breast cancer survivors: a pilot study.

Authors:  Diane B Wilson; Jerlym S Porter; Gwen Parker; James Kilpatrick
Journal:  Prev Chronic Dis       Date:  2005-03-15       Impact factor: 2.830

View more
  8 in total

1.  Associations between physical activity and comorbidities in Korean cancer survivors.

Authors:  Dong-Woo Kang; Eun-Young Lee; Ki Yong An; Jihee Min; Justin Y Jeon; Kerry S Courneya
Journal:  J Cancer Surviv       Date:  2018-03-01       Impact factor: 4.442

2.  The Impact of Exercise Training on Breast Cancer.

Authors:  Katarzyna Siewierska; Iwona Malicka; Christopher Kobierzycki; Urszula Paslawska; Marek Cegielski; Jedrzej Grzegrzolka; Aleksandra Piotrowska; Marzenna Podhorska-Okolow; Piotr Dziegiel; Marek Wozniewski
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

Review 3.  Metabolic syndrome induced by anticancer treatment in childhood cancer survivors.

Authors:  Hee Won Chueh; Jae Ho Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-06-28

4.  Prevalence of metabolic syndrome among breast cancer survivors in East Coast of Peninsular Malaysia.

Authors:  Mohd Razif Shahril; Syed Amirfaiz; Pei Lin Lua; Ali Nurnazahiah; Nor Syamimi Zakarai; Ving Lok Kow; Aryati Ahmad; Suhaina Sulaiman
Journal:  BMC Public Health       Date:  2021-01-28       Impact factor: 3.295

5.  Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods.

Authors:  Christina M Dieli-Conwright; Joanne E Mortimer; E Todd Schroeder; Kerry Courneya; Wendy Demark-Wahnefried; Thomas A Buchanan; Debu Tripathy; Leslie Bernstein
Journal:  BMC Cancer       Date:  2014-04-03       Impact factor: 4.430

6.  Increased depression and metabolic risk in postmenopausal breast cancer survivors.

Authors:  Monica C Serra; Andrew P Goldberg; Alice S Ryan
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

7.  Validity of treadmill- and track-based individual calibration methods for estimating free-living walking speed and VO2 using the Actigraph accelerometer.

Authors:  Anthony Barnett; Ester Cerin; Corneel Vandelanotte; Aya Matsumoto; David Jenkins
Journal:  BMC Sports Sci Med Rehabil       Date:  2015-11-25

Review 8.  MicroRNAs as Potential Biomarkers for Exercise-Based Cancer Rehabilitation in Cancer Survivors.

Authors:  Yanping Jiang; Kulsoom Ghias; Sanjeev Gupta; Ananya Gupta
Journal:  Life (Basel)       Date:  2021-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.